{"id":27956,"date":"2026-06-30T01:31:00","date_gmt":"2026-06-29T23:31:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=ab5812607eaca6d5781a4e6a711ffca4"},"modified":"2026-06-30T01:31:00","modified_gmt":"2026-06-29T23:31:00","slug":"inspire-medical-investigation-continued-kahn-swick-foti-llc-continues-to-investigate-the-officers-and-directors-of-inspire-medical-systems-inc-insp","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=27956","title":{"rendered":"Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. – INSP"},"content":{"rendered":"

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti<\/a>, LLC (\u201cKSF\u201d), announces that KSF continues its investigation into Inspire Medical<\/a> Systems, Inc. (NYSE: INSP).<\/p><\/a><\/a>

\nIn August of 2025, contrary to the Company\u2019s repeated assurances that it had met all regulatory, technical, and commercial prerequisites for the launch of its Inspire V device, the Company disclosed that the launch faced an \"elongated timeframe\" due to previously undisclosed issues, including that \u201cmany centers did not complete the training, contracting and onboarding criteria required prior to the purchase and implant of Inspire V,\u201d \u201csoftware updates for claims submissions and processing\u201d not taking effect until early July, and that excess inventory caused poor demand. As a result, the Company slashed its 2025 earnings guidance by more than 80%, from $2.20 to $2.30 per share to $0.40 to $0.50 per share.<\/p>

\nThereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information in violation of federal securities laws. Recently, the case was transferred from the United States District Court for the Southern District of New York to the District of Minnesota, and remains ongoing.<\/p>

\nKSF\u2019s investigation is focusing on whether Inspire\u2019s officers and\/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.<\/p>

\nIf you have information that would assist KSF in its investigation, or have been a long-term holder of Inspire shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-938-0905 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com<\/a>), or visit https:\/\/www.ksfcounsel.com\/cases\/nyse-insp\/<\/a> to learn more.<\/p>

\nAbout Kahn Swick & Foti, LLC<\/p>

\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\u2019s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.<\/p>

\nTOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services<\/p>

\nTo learn more about KSF, you may visit www.ksfcounsel.com<\/a>.<\/p>

\nCONNECT WITH US: Facebook<\/a> || Instagram<\/a> || YouTube<\/a> || TikTok<\/a> || LinkedIn<\/a><\/p> Contacts<\/b>

\nKahn Swick & Foti, LLC\nLewis Kahn, Managing Partner\nlewis.kahn@ksfcounsel.com<\/a>1-877-515-1850\n1100 Poydras St., Suite 960\nNew Orleans, LA 70163<\/p>","protected":false},"excerpt":{"rendered":"

NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (\u201cKSF\u201d), announces that KSF continues its investigation into Inspire Medical Systems, Inc…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-27956","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/27956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=27956"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/27956\/revisions"}],"predecessor-version":[{"id":27957,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/27956\/revisions\/27957"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=27956"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=27956"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=27956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}